Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
Authors
Keywords
-
Journal
PROTEOMICS
Volume 18, Issue 12, Pages 1700465
Publisher
Wiley
Online
2018-05-22
DOI
10.1002/pmic.201700465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GibbsCluster: unsupervised clustering and alignment of peptide sequences
- (2017) Massimo Andreatta et al. NUCLEIC ACIDS RESEARCH
- Cofilin-1 and Other ADF/Cofilin Superfamily Members in Human Malignant Cells
- (2016) Sergey Shishkin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gapped sequence alignment using artificial neural networks: application to the MHC class I system
- (2015) Massimo Andreatta et al. BIOINFORMATICS
- The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy
- (2015) S. Walz et al. BLOOD
- Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells
- (2015) Nicola Ternette et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Therapies for triple negative breast cancer
- (2015) Eleni Andreopoulou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry
- (2015) Etienne Caron et al. MOLECULAR & CELLULAR PROTEOMICS
- 2016 update of the PRIDE database and its related tools
- (2015) Juan Antonio Vizcaíno et al. NUCLEIC ACIDS RESEARCH
- The expression and clinical significance of ribophorin II (RPN2) in human breast cancer
- (2015) Makiko Ono et al. PATHOLOGY INTERNATIONAL
- An open-source computational and data resource to analyze digital maps of immunopeptidomes
- (2015) Etienne Caron et al. eLife
- Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
- (2014) C Berlin et al. LEUKEMIA
- HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
- (2014) Daniel J. Kowalewski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PCNA: a silent housekeeper or a potential therapeutic target?
- (2014) Shao-Chun Wang TRENDS IN PHARMACOLOGICAL SCIENCES
- Novel insights into the biology of interleukin-32
- (2013) Leo A. B. Joosten et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trials
- (2013) Sebastian P Haen et al. CURRENT OPINION IN IMMUNOLOGY
- HLA ligandome tumor antigen discovery for personalized vaccine approach
- (2013) Hans-Georg Rammensee et al. Expert Review of Vaccines
- Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3β
- (2013) Ryou-u Takahashi et al. Scientific Reports
- Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach
- (2012) Massimo Andreatta et al. BIOINFORMATICS
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- Clinical implication of HLA class I expression in breast cancer
- (2011) Koichi Kaneko et al. BMC CANCER
- Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2
- (2011) Yun Hee Kang et al. CANCER LETTERS
- Phase I Trial of ALT-801, an Interleukin-2/T-Cell Receptor Fusion Protein Targeting p53 (aa264-272)/HLA-A*0201 Complex, in Patients with Advanced Malignancies
- (2011) M. N. Fishman et al. CLINICAL CANCER RESEARCH
- Targeted therapies for breast cancer
- (2011) Michaela J. Higgins et al. JOURNAL OF CLINICAL INVESTIGATION
- An HLA-Presented Fragment of Macrophage Migration Inhibitory Factor Is a Therapeutic Target for Invasive Breast Cancer
- (2011) O. Hawkins et al. JOURNAL OF IMMUNOLOGY
- The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
- (2011) E. Caron et al. Molecular Systems Biology
- Translating Tumor Antigens into Cancer Vaccines
- (2010) Luigi Buonaguro et al. Clinical and Vaccine Immunology
- Expression of IL-32 in Human Lung Cancer Is Related to the Histotype and Metastatic Phenotype
- (2009) Carlo Sorrentino et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- PCNA on the crossroad of cancer
- (2009) Ivaylo Stoimenov et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- HLA ligand profiles of primary renal cell carcinoma maintained in metastases
- (2009) Juliane Sarah Stickel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin-32 Expression in the Pancreas
- (2009) Atsushi Nishida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines
- (2009) Kwasi Antwi et al. MOLECULAR IMMUNOLOGY
- Identification of Breast Cancer Peptide Epitopes Presented by HLA-A*0201
- (2008) Oriana E. Hawkins et al. JOURNAL OF PROTEOME RESEARCH
- RPN2 gene confers docetaxel resistance in breast cancer
- (2008) Kimi Honma et al. NATURE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started